Cell‐Type‐Dependent Up‐Regulation of In Vitro Mineralization After Overexpression of the Osteoblast‐Specific Transcription Factor Runx2/Cbfa1

Functional expression of the transcriptional activator Runx2/Cbfa1 is essential for osteoblastic differentiation and bone formation and maintenance. Forced expression of Runx2 in nonosteoblastic cells induces expression of osteoblast‐specific genes, but the effects of Runx2 overexpression on in vitro matrix mineralization have not been determined. To examine whether exogenous Runx2 expression is sufficient to direct in vitro mineralization, we investigated sustained expression of Runx2 in nonosteoblastic and osteoblast‐like cell lines using retroviral gene delivery. As expected, forced expression of Runx2 induced several osteoblast‐specific genes in NIH3T3 and C3H10T1/2 fibroblasts and up‐regulated expression in MC3T3‐E1 immature osteoblast‐like cells. However, Runx2 expression enhanced matrix mineralization in a cell‐type‐dependent manner. NIH3T3 and IMR‐90 fibroblasts overexpressing Runx2 did not produce a mineralized matrix, indicating that forced expression of Runx2 in these nonosteogenic cell lines is not sufficient to direct in vitro mineralization. Consistent with the pluripotent nature of the cell line, a fraction (25%) of Runx2‐expressing C3H10T1/2 fibroblast cultures produced mineralized nodules in a viral supernatant‐dependent manner. Notably, bone sialoprotein (BSP) gene expression was detected at significantly higher levels in mineralizing Runx2‐infected C3H10T1/2 cells compared with Runx2‐expressing cultures which did not mineralize. Treatment of Runx2‐infected C3H10T1/2 cultures with dexamethasone enhanced osteoblastic phenotype expression, inducing low levels of mineralization independent of viral supernatant. Finally, Runx2 overexpression in immature osteoblast‐like MC3T3‐E1 cells resulted in acceleration and robust up‐regulation of matrix mineralization compared with controls. These results suggest that, although functional Runx2 is essential to multiple osteoblast‐specific activities, in vitro matrix mineralization requires additional tissue‐specific cofactors, which supplement Runx2 activity.

[1]  G. Stein,et al.  CCAAT/Enhancer-binding Proteins (C/EBP) β and δ Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific Expression* , 2002, The Journal of Biological Chemistry.

[2]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[3]  B. L. Riggs,et al.  Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  N. Kanatani,et al.  Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures , 2001, The Journal of cell biology.

[5]  P. Angel,et al.  AP-1 and Cbfa/Runt Physically Interact and Regulate Parathyroid Hormone-dependent MMP13 Expression in Osteoblasts through a New Osteoblast-specific Element 2/AP-1 Composite Element* , 2001, The Journal of Biological Chemistry.

[6]  N. Kanatani,et al.  Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.

[7]  G. Karsenty,et al.  Cbfa1 Contributes to the Osteoblast-specific Expression of type I collagen Genes* , 2001, The Journal of Biological Chemistry.

[8]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[9]  T. Murphy,et al.  Evidence that Galpha(q)-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. , 2000, Molecular pharmacology.

[10]  J. Millán,et al.  Functional Characterization of Osteoblasts and Osteoclasts from Alkaline Phosphatase Knockout Mice , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Y. Kitamura,et al.  Cbfa1 Is a Positive Regulatory Factor in Chondrocyte Maturation* , 2000, The Journal of Biological Chemistry.

[12]  G. Karsenty,et al.  The Mammalian Basic Helix Loop Helix Protein HES-1 Binds to and Modulates the Transactivating Function of the Runt-related Factor Cbfa1* , 2000, The Journal of Biological Chemistry.

[13]  G. Karsenty,et al.  Inhibition of Osteoblast-specific Transcription Factor Cbfa1 by the cAMP Pathway in Osteoblastic Cells , 1999, The Journal of Biological Chemistry.

[14]  L. Quarles,et al.  Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non‐osteoblastic and pre‐osteoblastic cells , 1999, Journal of cellular biochemistry.

[15]  J. Nalbantoglu,et al.  Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. , 1999, Cancer research.

[16]  G. Karsenty,et al.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.

[17]  G. Stein,et al.  Transient upregulation of CBFA1 in response to bone morphogenetic protein‐2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation , 1999, Journal of cellular biochemistry.

[18]  S. Nomura,et al.  Maturational disturbance of chondrocytes in Cbfa1‐deficient mice , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  T. Komori,et al.  Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation* , 1999, The Journal of Biological Chemistry.

[20]  J. Aubin,et al.  Cloning of a 2.5 kb Murine Bone Sialoprotein Promoter Fragment and Functional Analysis of Putative Osf2 Binding Sites , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  S. Mundlos,et al.  Regulation of chondrocyte differentiation by Cbfa1 , 1999, Mechanisms of Development.

[22]  Renny T. Franceschi,et al.  Role of the α2-Integrin in Osteoblast-specific Gene Expression and Activation of the Osf2 Transcription Factor* , 1998, The Journal of Biological Chemistry.

[23]  G. Pavlath,et al.  Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. , 1998, Molecular biology of the cell.

[24]  Takahiro Ochi,et al.  Transcriptional regulation of osteopontin gene in vivo by PEBP2αA/CBFA1 and ETS1 in the skeletal tissues , 1998, Oncogene.

[25]  T. Steinberg,et al.  Gap junctional communication modulates gene expression in osteoblastic cells. , 1998, Molecular biology of the cell.

[26]  R. Thomas,et al.  Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. , 1998, Gene.

[27]  G. Karsenty,et al.  Two Domains Unique to Osteoblast-Specific Transcription Factor Osf2/Cbfa1 Contribute to Its Transactivation Function and Its Inability To Heterodimerize with Cbfβ , 1998, Molecular and Cellular Biology.

[28]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[29]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[30]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[31]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[32]  H. Blau,et al.  High-efficiency retroviral infection of primary myoblasts , 1997, Somatic cell and molecular genetics.

[33]  A. Boskey,et al.  The mechanism of β‐glycerophosphate action in mineralizing chick limb‐bud mesenchymal cell cultures , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  N. Lenny,et al.  AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. , 1996, Oncogene.

[35]  P. Hauschka,et al.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. , 1996, The Biochemical journal.

[36]  In‐San Kim,et al.  Expression patterns of bone‐related proteins during osteoblastic differentiation in MC3T3‐E1 cells , 1996, Journal of cellular biochemistry.

[37]  S. Aota,et al.  Fibronectin regulates calvarial osteoblast differentiation. , 1996, Journal of cell science.

[38]  G. Karsenty,et al.  A PEBP2/AML-1-related Factor Increases Osteocalcin Promoter Activity through Its Binding to an Osteoblast-specific cis-Acting Element (*) , 1995, The Journal of Biological Chemistry.

[39]  R. Franceschi,et al.  Mineralization of bone‐like extracellular matrix in the absence of functional osteoblasts , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  G. Stein,et al.  The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. , 1995, Biochemistry.

[41]  Ping Liu,et al.  Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. , 1995, Genomics.

[42]  N. Lenny,et al.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation , 1995, Molecular and cellular biology.

[43]  G. Karsenty,et al.  Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene , 1995, Molecular and cellular biology.

[44]  I. Bar-Am,et al.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. , 1994, Genomics.

[45]  J. Wozney,et al.  Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Ohki,et al.  The Runt domain identifies a new family of heteromeric transcriptional regulators. , 1993, Trends in genetics : TIG.

[47]  Y. Ito,et al.  PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Y. Yamaguchi-Iwai,et al.  Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. , 1993, Oncogene.

[49]  F. Calabi,et al.  Leukaemia/Drosophila homology , 1992, Nature.

[50]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Devlin,et al.  Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures , 1991, Journal of cellular physiology.

[52]  V. Rosen,et al.  The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. , 1990, Biochemical and biophysical research communications.

[53]  G. Stein,et al.  Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  G. Rodan,et al.  Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  J B Lian,et al.  Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. , 1989, Physiological reviews.

[56]  J Dequeker,et al.  Biochemistry of bone. , 1988, Bailliere's clinical rheumatology.

[57]  J. Aubin,et al.  Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. , 1987, Endocrinology.

[58]  E. Wieschaus,et al.  The localized requirements for a gene affecting segmentation in Drosophila: analysis of larvae mosaic for runt. , 1985, Developmental biology.

[59]  Y. Amagai,et al.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.

[60]  G. Stein,et al.  CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. , 2002, The Journal of biological chemistry.

[61]  Yoshiaki Ito,et al.  Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain , 1995 .

[62]  Y. Ito,et al.  Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. , 1995, Gene.

[63]  W F Anderson,et al.  Improved methods of retroviral vector transduction and production for gene therapy. , 1994, Human gene therapy.

[64]  G. Nolan,et al.  Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[65]  N. Speck,et al.  Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. , 1992, Molecular and cellular biology.

[66]  J Sodek,et al.  Bone cell cultures. , 1987, Methods in enzymology.